TP53 and neoplasm: Reactivation of p53 appears as a pertinent strategy for numerous tumors (Selivanova, 2014) and, as suggested above, blocking either integrins or their downstream signaling pathways may offer new opportunities to synergistically enhance the p53 tumor suppressor effects.